Determination of melanin synthetic pathways.

Visible pigmentation of the skin, hair, and eyes depends primarily on the presence of melanin(s) in those tissues. Melanins are produced by specific cells called melanocytes. Not only is the type of melanin produced important, but also its eventual distribution in the tissue dramatically affects visible color, which ultimately determines the functions of the pigment, such as photoprotection (Gilchrest, 2011). Clearly, the specification, migration, and differentiation during development of melanocyte precursors (‘‘melanoblasts’’) in specific patterns are essential for eventual pigmentation in adults (Kawakami and Fisher, 2011). Following is a synopsis of critical findings that have led to our current understanding of the biochemical pathways and melanogenic factors involved in melanin synthesis. The key enzyme involved in the synthesis of all types of melanins from the initial precursor tyrosine is tyrosinase (EC 1.14.18.1). Tyrosinases have been described in many species, including mammals and lower animals, plants, and even fungi; in fact, the earliest observations of the catalytic function of tyrosinase were made in extracts of mushrooms (Bourquelot and Bertrand, 1895), which are still widely used today as a highly enriched source of that enzyme. All tyrosinases depend on the binding of copper for their catalytic function (Lerner et al., 1950; Lerch et al., 1986), although their substrate specificities and physical properties can differ dramatically depending on the species (Lerner et al., 1951; Hearing et al., 1980). The ratelimiting initial step in the biosynthesis of melanin was initially thought to be the hydroxylation of tyrosine to L-3,4dihydroxyphenylalanine (DOPA) and its immediate subsequent oxidation to DOPAquinone (DQ). In melanocytic cells, the DQ formed will be spontaneously converted to an orangecolored intermediate known as DOPAchrome. In vitro, the DOPAchrome will spontaneously lose its carboxylic acid group to form 5,6-dihydroxyindole (DHI), which can then further oxidize and polymerize to form a dense, highmolecular-weight complex now known as DHI-melanin. This was initially reported by Raper (1926), and the pathway was later refined by Mason (1948); hence, the biosynthetic pathway is frequently referred to as the Raper–Mason pathway. Throughout the 1950s, 1960s, and 1970s, the collaborative research groups at Yale (headed by AB Lerner) and Harvard (headed by TB Fitzpatrick) played key roles in defining the involvement of tyrosinase in the human skin pigmentation (Fitzpatrick et al., 1950), how its activities were confined to melanosomes and how those organelles developed (Seiji et al., 1961; Szabo et al., 1969), and the disruptions that occurred in those processes in many skin pigmentary diseases (Breathnach et al., 1965; Kawamura et al., 1971; Lerner and Nordlund, 1978; Rees, 2011; Spritz, 2011). Those findings, plus the training of many post-doctoral fellows and clinicians in their groups, played a major role in establishing research centers in Asia, Europe, and the Americas, which still have a strong influence on studies of skin pigmentation and related pigmentary diseases. As summarized in Figure 1, recent revisions of this melanogenic pathway have shown that DOPA is not a distinct intermediate produced initially from tyrosine, but is in fact produced later in the pathway owing to the paired reduction of DQ (Riley, 1999), and that downstream tyrosinase-related enzymes can rearrange the DOPAchrome to form a carboxylated intermediate (DHI-2-carboxylic acid) known as DHICA, as discussed below. Analysis of the structures of the high-molecular-weight polymers of melanins depended on the development of new techniques to analyze these intractable pigments, and gradual progress was made in defining those structures, initially by Nicolaus’s group in Naples and Swan’s group in the United Kingdom (Swan, 1963; Nicolaus et al., 1964). In working with melanins found in nature, it quickly became apparent that there were two major types, the brown–black melanins now collectively known as eumelanins, and the yellow–red melanins now collectively known as pheomelanins. Prota’s group in Naples took the lead in defining the structure of pheomelanin and the involvement of sulfur as responsible for its unique color and properties (Prota, 1980). Prota and colleagues, as well as Ito and Wakamatsu in Japan (Ito et al., 1984), developed a series of more sensitive and specific assays for eumelanin and pheomelanin intermediates that gradually formed the basis for our understanding of how they are formed in melanocytes and how they are copolymerized in situ. The critical role of sulfhydryl groups in reacting immediately with DQ upon its formation to form various combinations of cysteinylDOPAs and downstream reactions of those intermediates, via cysteinylDOPA-quinones and benzothiazine intermediates, to produce

[1]  J. Rees The genetics of human pigmentary disorders. , 2011, Journal of Investigative Dermatology.

[2]  E. Fattorusso,et al.  The structure of melanins and melanogenesis. IV. On some natural melanins. , 1964, Tetrahedron.

[3]  J. Pawelek,et al.  Dopachrome conversion: a possible control point in melanin biosynthesis. , 1980, The Journal of investigative dermatology.

[4]  D. Fisher,et al.  Key discoveries in melanocyte development. , 2011, The Journal of investigative dermatology.

[5]  A. Baranova,et al.  Evidence for the ectopic synthesis of melanin in human adipose tissue , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  B. Linzen,et al.  Different origins of metal binding sites in binuclear copper proteins, tyrosinase and hemocyanin , 1986 .

[7]  S. Orlow,et al.  High-molecular-weight forms of tyrosinase and the tyrosinase-related proteins: evidence for a melanogenic complex. , 1994, The Journal of investigative dermatology.

[8]  B. Kwon,et al.  Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[9]  R. Spritz Molecular genetics of oculocutaneous albinism. , 1993, Seminars in Dermatology.

[10]  H. Raper The Tyrosinase-Tyrosine Reaction: Production of l-3.4-Dihydroxyphenylalanine from Tyrosine. , 1926, The Biochemical journal.

[11]  B. Gilchrest Molecular aspects of tanning. , 2011, The Journal of investigative dermatology.

[12]  F. C. Brito,et al.  Timeline and distribution of melanocyte precursors in the mouse heart , 2008, Pigment cell & melanoma research.

[13]  V. Ferrans,et al.  Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild‐type proteins , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  J. Nordlund,et al.  Vitiligo: What Is It? Is It Important? , 1978 .

[15]  G. Raposo,et al.  Pmel17 initiates premelanosome morphogenesis within multivesicular bodies. , 2001, Molecular biology of the cell.

[16]  T. Sarna,et al.  Properties and function of the ocular melanin--a photobiophysical view. , 1992, Journal of photochemistry and photobiology. B, Biology.

[17]  J. Nordlund The pigmentary system : physiology and pathophysiology , 1998 .

[18]  E. Fattorusso,et al.  The structure of melanins and melanogenesis—V , 1965 .

[19]  G. A. Swan CHEMICAL STRUCTURE OF MELANINS , 1963, Annals of the New York Academy of Sciences.

[20]  J. Ortonne,et al.  What are melanocytes really doing all day long…? , 2009, Experimental dermatology.

[21]  T. Fitzpatrick,et al.  Mammalian tyrosinase; action on substances structurally related to tyrosine. , 1951, The Journal of biological chemistry.

[22]  A. Napolitano,et al.  Characterisation of 1,4-benzothiazine intermediates in the oxidative conversion of 5-S-cysteinyldopa to pheomelanins , 1994 .

[23]  V. Hearing,et al.  From Melanocytes to Melanoma : The Progression to Malignancy , 2005 .

[24]  T. Fitzpatrick,et al.  The melanosome: a distinctive subcellular particle of mammalian melanocytes and the site of melanogenesis. , 1961, The Journal of investigative dermatology.

[25]  M. d’Ischia,et al.  Effect of metal ions on the rearrangement of dopachrome. , 1987, Biochimica et biophysica acta.

[26]  N. Turro,et al.  New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals , 2008, Proceedings of the National Academy of Sciences.

[27]  D. Sulzer,et al.  Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour , 2001, Molecular pathology : MP.

[28]  T. Fitzpatrick,et al.  Tyrosinase in human skin: demonstration of its presence and of its role in human melanin formation. , 1950, Science.

[29]  H. S. Mason The chemistry of melanin; mechanism of the oxidation of dihydroxyphenylalanine by tyrosinase. , 1948, The Journal of biological chemistry.

[30]  K. Wakamatsu,et al.  Pheomelanin as well as eumelanin is present in human epidermis. , 1991, The Journal of investigative dermatology.

[31]  V. Hearing,et al.  Update on the regulation of mammalian melanocyte function and skin pigmentation. , 2011, Expert review of dermatology.

[32]  N. Gibbs,et al.  Urocanic acid in the skin: a mixed blessing? , 2011, The Journal of investigative dermatology.

[33]  N. Copeland,et al.  A second tyrosinase‐related protein, TRP‐2, maps to and is mutated at the mouse slaty locus. , 1992, The EMBO journal.

[34]  V. Hearing,et al.  Tyrosinase processing and intracellular trafficking is disrupted in mouse primary melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous albinism (OCA) type 4 , 2003, Journal of Cell Science.

[35]  T. Fitzpatrick,et al.  Mammalian tyrosinase; the relationship of copper to enzymatic activity. , 1950, The Journal of biological chemistry.

[36]  Riley Pa The great DOPA mystery: the source and significance of DOPA in phase I melanogenesis. , 1999 .

[37]  H. Williams Eczema across the world: the missing piece of the jigsaw revealed. , 2011, The Journal of investigative dermatology.

[38]  G. Prota Recent advances in the chemistry of melanogenesis in mammals. , 1980, The Journal of investigative dermatology.

[39]  I. Jackson,et al.  A second tyrosinase‐related protein, TRP‐2, is a melanogenic enzyme termed DOPAchrome tautomerase. , 1992, The EMBO journal.

[40]  E. Rosengren,et al.  Intracellular distribution of dopa and 5-S-cysteinyldopa in pigment cells with minimal pigment formation. , 1979, Acta dermato-venereologica.

[41]  R. Spritz The genetics of vitiligo. , 2011, The Journal of investigative dermatology.

[42]  T. Fitzpatrick,et al.  Racial Differences in the Fate of Melanosomes in Human Epidermis , 1969, Nature.

[43]  T. Fitzpatrick,et al.  ELECTRON MICROSCOPY OF MELANOCYTES IN HUMAN PIEBALDISM. , 1965, The Journal of investigative dermatology.

[44]  S. Ito,et al.  Characterization of melanogenesis in mouse and guinea pig hair by chemical analysis of melanins and of free and bound dopa and 5-S-cysteinyldopa. , 1984, The Journal of investigative dermatology.

[45]  M. Adinolfi,et al.  Disentangling eumelanin "black chromophore": visible absorption changes as signatures of oxidation state- and aggregation-dependent dynamic interactions in a model water-soluble 5,6-dihydroxyindole polymer. , 2009, Journal of the American Chemical Society.

[46]  W. Oetting,et al.  Molecular basis of oculocutaneous albinism. , 1994, The Journal of investigative dermatology.

[47]  V. Hearing,et al.  Mammalin tyrosinase. Stoichiometry and measurement of reaction products. , 1980, Biochimica et biophysica acta.

[48]  R. Nicolaus,et al.  Structure of melanins and melanogenesis , 1962 .

[49]  S. Ito,et al.  Microanalysis of eumelanin and pheomelanin in hair and melanomas by chemical degradation and liquid chromatography. , 1985, Analytical biochemistry.

[50]  K. Wakamatsu,et al.  Comparison of Structural and Chemical Properties of Black and Red Human Hair Melanosomes¶ , 2005, Photochemistry and photobiology.